insights_auto
Why is SBS up 4,09%?
Dive Deeperchevron_right
SBS:ETR
Stratec SE
€22,90
arrow_upward
+4,09%(+0,90) 1D
9 ຕ.ລ., 17 ໂມງ 35 ນາທີ 38 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SBS...
Open
€22,00
High
€23,05
Low
€22,00
Mkt. cap
273,14 ລ້ານ
Avg. vol.
13,74 ພັນ
Volume
10,43 ພັນ
Dividend
2,62%
Quarterly dividend
€0,15
Ex-dividend date
24 ມິ.ຖ. 2026
52-wk high
€30,50
52-wk low
€16,30
EPS
€-0,03
Shares outstanding
12,16 ລ້ານ
No. of employees
1 ພັນ
Open
€22,00
High
€23,05
Low
€22,00
Mkt. cap
273,14 ລ້ານ
Avg. vol.
13,74 ພັນ
Volume
10,43 ພັນ
Dividend
2,62%
Quarterly dividend
€0,15
Ex-dividend date
24 ມິ.ຖ. 2026
52-wk high
€30,50
52-wk low
€16,30
EPS
€-0,03
Shares outstanding
12,16 ລ້ານ
No. of employees
1 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
·
1 ມື້ກ່ອນ
mwb research downgrades Stratec stock as execution risks rise in 2026
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE